Safety and tolerability of omalizumab (Xolair®), a recombinant humanized monoclonal anti-IgE antibody

Author: Deniz Yamo   Gupta Niroo  

Publisher: Humana Press, Inc

ISSN: 1080-0549

Source: Clinical Reviews in Allergy and Immunology, Vol.29, Iss.1, 2005-02, pp. : 31-48

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract